SALIX PHARMACEUTICALS LTD·4

Feb 4, 5:06 PM ET

SALIX PHARMACEUTICALS LTD 4

4 · SALIX PHARMACEUTICALS LTD · Filed Feb 4, 2015

Insider Transaction Report

Form 4
Period: 2015-02-02
Transactions
  • Award

    Common Stock

    2015-02-02+14,66295,587 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,080
  • Common Stock

    (indirect: By Spouse)
    6,500
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: By Trust)
    10,450
  • Common Stock

    (indirect: By LP)
    260
Footnotes (4)
  • [F1]Represents a restricted stock award of which one-half will vest on each of the six-month anniversary and the twelve-month anniversary of the grant date, subject to Mr. D'Alonzo's continued employment as Acting Chief Executive Officer of the Issuer.
  • [F2]The shares are held by the Thomas W. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  • [F3]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
  • [F4]Options are 100% vested.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4